Pinpointing new protein and phosphoprotein biomarkers in rheumatoid arthritis by high-resolution label-free mass spectrometry analysis of liquid biopsies
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Tipo de documento: | Dissertação |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/90818 |
Resumo: | Rheumatoid arthritis is an autoimmune inflammatory disease that attacks the joints, leading to joint destruction, if left untreated. The disease affects 0.5 to 1 % of the population in developed countries and causes great impairment to those affected and may even lead to early mortality, since the disease is usually correlated to cardiovascular events. Premature diagnosis and treatment are of the utmost importance, since it has been proved that people who began treatment within 3 months of disease onset had better outcomes, usually being able to avoid cartilage destruction in the joints. This work has the primary goal of identifying potential biomarkers in serum samples of patients with rheumatoid arthritis. Another objective was to check the phosphoproteome for differently phosphorylated peptides. In order to achieve these goals, we employed liquid chromatography-mass spectrometry to perform Label-Free Quantification of the non-phosphorylated fraction of the proteome, as well as for identifying the peptide sequences and phosphorylation present on the phosphoproteome of the different conditions. We compared serum samples from rheumatoid arthritis to healthy donors and to patients with systemic lupus erythematosus, another autoimmune disease characterised by chronic inflammation. We were able to identify 43 proteins, that were differently expressed between rheumatoid arthritis and healthy subjects. 12 of these were specific to rheumatoid arthritis. We were also able to identify 41 peptides that possessed different phosphorylation patterns between rheumatoid arthritis and healthy subjects. It was also possible to identify a kinase that appears to be active in rheumatoid arthritis, but not in healthy subjects. |
id |
RCAP_d03786fd6b99ce6a5cd5e84636699394 |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/90818 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Pinpointing new protein and phosphoprotein biomarkers in rheumatoid arthritis by high-resolution label-free mass spectrometry analysis of liquid biopsiesRheumatoid ArthritisBiomarkerLiquid Chromatography-Mass SpectrometryProteomicsSerumDomínio/Área Científica::Engenharia e Tecnologia::Engenharia QuímicaRheumatoid arthritis is an autoimmune inflammatory disease that attacks the joints, leading to joint destruction, if left untreated. The disease affects 0.5 to 1 % of the population in developed countries and causes great impairment to those affected and may even lead to early mortality, since the disease is usually correlated to cardiovascular events. Premature diagnosis and treatment are of the utmost importance, since it has been proved that people who began treatment within 3 months of disease onset had better outcomes, usually being able to avoid cartilage destruction in the joints. This work has the primary goal of identifying potential biomarkers in serum samples of patients with rheumatoid arthritis. Another objective was to check the phosphoproteome for differently phosphorylated peptides. In order to achieve these goals, we employed liquid chromatography-mass spectrometry to perform Label-Free Quantification of the non-phosphorylated fraction of the proteome, as well as for identifying the peptide sequences and phosphorylation present on the phosphoproteome of the different conditions. We compared serum samples from rheumatoid arthritis to healthy donors and to patients with systemic lupus erythematosus, another autoimmune disease characterised by chronic inflammation. We were able to identify 43 proteins, that were differently expressed between rheumatoid arthritis and healthy subjects. 12 of these were specific to rheumatoid arthritis. We were also able to identify 41 peptides that possessed different phosphorylation patterns between rheumatoid arthritis and healthy subjects. It was also possible to identify a kinase that appears to be active in rheumatoid arthritis, but not in healthy subjects.Santos, HugoRUNPrates, João Alexandre Martins Forreta2021-10-01T00:30:31Z2019-12-1020192019-12-10T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/90818enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T04:40:19Zoai:run.unl.pt:10362/90818Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:37:11.208215Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Pinpointing new protein and phosphoprotein biomarkers in rheumatoid arthritis by high-resolution label-free mass spectrometry analysis of liquid biopsies |
title |
Pinpointing new protein and phosphoprotein biomarkers in rheumatoid arthritis by high-resolution label-free mass spectrometry analysis of liquid biopsies |
spellingShingle |
Pinpointing new protein and phosphoprotein biomarkers in rheumatoid arthritis by high-resolution label-free mass spectrometry analysis of liquid biopsies Prates, João Alexandre Martins Forreta Rheumatoid Arthritis Biomarker Liquid Chromatography-Mass Spectrometry Proteomics Serum Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química |
title_short |
Pinpointing new protein and phosphoprotein biomarkers in rheumatoid arthritis by high-resolution label-free mass spectrometry analysis of liquid biopsies |
title_full |
Pinpointing new protein and phosphoprotein biomarkers in rheumatoid arthritis by high-resolution label-free mass spectrometry analysis of liquid biopsies |
title_fullStr |
Pinpointing new protein and phosphoprotein biomarkers in rheumatoid arthritis by high-resolution label-free mass spectrometry analysis of liquid biopsies |
title_full_unstemmed |
Pinpointing new protein and phosphoprotein biomarkers in rheumatoid arthritis by high-resolution label-free mass spectrometry analysis of liquid biopsies |
title_sort |
Pinpointing new protein and phosphoprotein biomarkers in rheumatoid arthritis by high-resolution label-free mass spectrometry analysis of liquid biopsies |
author |
Prates, João Alexandre Martins Forreta |
author_facet |
Prates, João Alexandre Martins Forreta |
author_role |
author |
dc.contributor.none.fl_str_mv |
Santos, Hugo RUN |
dc.contributor.author.fl_str_mv |
Prates, João Alexandre Martins Forreta |
dc.subject.por.fl_str_mv |
Rheumatoid Arthritis Biomarker Liquid Chromatography-Mass Spectrometry Proteomics Serum Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química |
topic |
Rheumatoid Arthritis Biomarker Liquid Chromatography-Mass Spectrometry Proteomics Serum Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química |
description |
Rheumatoid arthritis is an autoimmune inflammatory disease that attacks the joints, leading to joint destruction, if left untreated. The disease affects 0.5 to 1 % of the population in developed countries and causes great impairment to those affected and may even lead to early mortality, since the disease is usually correlated to cardiovascular events. Premature diagnosis and treatment are of the utmost importance, since it has been proved that people who began treatment within 3 months of disease onset had better outcomes, usually being able to avoid cartilage destruction in the joints. This work has the primary goal of identifying potential biomarkers in serum samples of patients with rheumatoid arthritis. Another objective was to check the phosphoproteome for differently phosphorylated peptides. In order to achieve these goals, we employed liquid chromatography-mass spectrometry to perform Label-Free Quantification of the non-phosphorylated fraction of the proteome, as well as for identifying the peptide sequences and phosphorylation present on the phosphoproteome of the different conditions. We compared serum samples from rheumatoid arthritis to healthy donors and to patients with systemic lupus erythematosus, another autoimmune disease characterised by chronic inflammation. We were able to identify 43 proteins, that were differently expressed between rheumatoid arthritis and healthy subjects. 12 of these were specific to rheumatoid arthritis. We were also able to identify 41 peptides that possessed different phosphorylation patterns between rheumatoid arthritis and healthy subjects. It was also possible to identify a kinase that appears to be active in rheumatoid arthritis, but not in healthy subjects. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-12-10 2019 2019-12-10T00:00:00Z 2021-10-01T00:30:31Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/90818 |
url |
http://hdl.handle.net/10362/90818 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799137988973690880 |